Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged ≥13 years
CONCLUSIONS: Improvements in prurigo nodularis were greater following nemolizumab treatment, despite continuation of topical corticosteroids in both groups. (Funded by Maruho; jRCT number, 2011200017.).PMID:38629497 | DOI:10.1093/bjd/ljae131
Source: The British Journal of Dermatology - Category: Dermatology Authors: Hiroo Yokozeki Hiroyuki Murota Takayo Matsumura Hiroshi Komazaki Nemolizumab-JP11 Study Group Source Type: research
More News: Corticosteroid Therapy | Dermatology | Japan Health | Skin | Sleep Disorders | Sleep Medicine | Study | UK Health